• iSpecimen received a Nasdaq notice on May 29, 2026 for failing the $2.5 million minimum stockholders’ equity requirement under Listing Rule 5550(b)(1).
• Stockholders’ equity stood at $814,038 as of March 31, 2026, below Nasdaq’s continued listing threshold.
• Shares continue trading on the Nasdaq Capital Market under ISPC, with no immediate impact from the notice.
• A compliance plan is due within 45 days; Nasdaq could grant up to 180 days from the notice date to regain compliance.
• Failure to win acceptance of the plan could lead to a Nasdaq hearings panel appeal process.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iSpecimen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-063575), on June 01, 2026, and is solely responsible for the information contained therein.